India Neurodegenerative Disease Market Research Report By Disease Type (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Huntington's Disease), By Diagnosis Method (Neurological Examination, Imaging Techniques, Cerebrospinal Fluid Analysis, Electrophysiological Tests), By Treatment Type (Medication, Therapy, Rehabilitation, Surgical Interventions) and By Route of Administration (Oral, Injectable, Intravenous, Transdermal)-Forecast to 2035

India Neurodegenerative Disease Market Overview

As per MRFR analysis, the India Neurodegenerative Disease Market Size was estimated at 1.1 (USD Billion) in 2023. The India Neurodegenerative Disease Market Industry is expected to grow from 1.5(USD Billion) in 2024 to 4 (USD Billion) by 2035. The India Neurodegenerative Disease Market CAGR (growth rate) is expected to be around 9.326% during the forecast period (2025 - 2035).

Key India Neurodegenerative Disease Market Trends Highlighted

The India Neurodegenerative Disease Market is currently experiencing significant growth driven by several key market drivers. An increasing aging population in India is one of the primary factors, as older adults are more susceptible to neurodegenerative diseases such as Alzheimer's and Parkinson's. The rise in lifestyle-related risk factors, coupled with advancements in neuroimaging and biomarker technologies, is enhancing disease detection and diagnostic capabilities, contributing to market growth.
Additionally, the Indian government has been actively promoting healthcare initiatives, focusing on improving mental health infrastructure and supporting research in neurodegenerative conditions. Opportunities in the India Neurodegenerative Disease Market are vast, especially in the realm of drug development and therapeutic interventions. With a growing demand for innovative treatment options, there is room for the introduction of newer drugs and personalized medicine approaches. Collaborative efforts between the public and private sectors can enhance research and development, fostering an environment conducive to healthcare advancements.
The increasing awareness of mental health and neurodegenerative disorders also presents a chance for educational campaigns to promote early diagnosis and treatment options. Trends in recent times show that there is a shift toward digital health solutions, including telemedicine and mobile health applications, to manage neurodegenerative diseases more effectively.
These technologies provide better access to specialists and facilitate ongoing care, particularly in rural areas where healthcare services may be limited. Furthermore, there is a growing emphasis on patient-centric care, where treatment plans are tailored to individual needs based on the distinct nature of various neurodegenerative diseases. Overall, the combination of these trends and the evolving healthcare landscape points towards a promising future for the neurodegenerative disease market in India.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

India Neurodegenerative Disease Market Drivers

Increasing Prevalence of Neurodegenerative Diseases

The rising frequency of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease in India is a major driving force in the India Neurodegenerative Disease Market. According to the Ministry of Health and Family Welfare, Alzheimer's disease is predicted to affect around 4.7 million people in India in recent years. Furthermore, recorded instances have increased by 20% in the previous decade, which might be ascribed to the country's aging population and rising life expectancy.
According to research from the Indian Council of Medical Research, the number of people aged 60 and older would reach almost 300 million by 2050, increasing the demand for effective neurodegenerative disease treatments and supportive services.
This rising patient population demands ongoing research and development (R&D) by pharmaceutical firms such as Sun Pharmaceutical Industries Limited, which invests substantially in creating new medicines suited to specific illnesses. As the number of patients grows, so does the demand for novel therapies, boosting the India Neurodegenerative Disease Market.

Enhancements in Healthcare Infrastructure

The ongoing enhancements in healthcare infrastructure across India are propelling the growth of the India Neurodegenerative Disease Market Industry. With initiatives like the Ayushman Bharat scheme, which aims to provide health insurance coverage to over 500 million underprivileged citizens, there is improved access to healthcare facilities and treatments for neurodegenerative diseases.
The Government of India has allocated substantial funds to improve hospital facilities and increase the number of neurological specialists, resulting in an augmented capacity to diagnose and treat these disorders.According to the National Health Authority, there was a 15% increase in the setup of specialized neurology centers between 2018 and 2021, allowing for better patient management and care. This investment in infrastructure facilitates timely diagnosis and effective management of neurodegenerative diseases, further stimulating the market.

Advancements in Therapeutics and Research

Research and Development efforts in the field of neurodegenerative diseases are rapidly advancing, bolstered by both public and private sector investments. The Government of India, through its National Bio-Pharma Mission, is investing significantly to promote biopharmaceutical innovations in the country, with a priority on progressive technologies for the treatment of neurodegenerative conditions.
Establishments such as the Institute of Neuroscience in Kolkata are at the forefront of ground-breaking research, focusing on novel therapies that show promise in combating the effects of these diseases.The increase in collaborations between domestic and international entities, as reported by the Department of Biotechnology in India, has observed a 25% rise in joint clinical trials for neurological therapies over the past five years. Such advancements are critical for addressing the high unmet medical needs in this area, thereby driving the growth of the India Neurodegenerative Disease Market.

India Neurodegenerative Disease Market Segment Insights

Neurodegenerative Disease Market Disease Type Insights

The India Neurodegenerative Disease Market, particularly in the context of Disease Type, highlights a diversity of debilitating conditions that significantly impact the population. Alzheimer's Disease remains a crucial area of focus, emerging as one of the leading causes of cognitive decline among elderly patients, thereby placing a considerable burden on caregivers and healthcare services.
Meanwhile, Parkinson's Disease is notable for its contribution to motor dysfunction and quality of life challenges faced by individuals, necessitating targeted therapeutic strategies and ongoing Research and Development initiatives.In parallel, Multiple Sclerosis has attracted attention due to its complex pathophysiology and episodic nature, resulting in a need for innovative treatment approaches tailored to the fluctuating symptoms experienced by patients.
Moreover, Amyotrophic Lateral Sclerosis presents unique challenges due to its rapid progression and impact on neuro-motor functions, requiring a multifaceted approach that includes palliative care and advanced therapeutics. Huntington's Disease, with its genetic basis, underscores the importance of early diagnosis and long-term management plans aimed at improving patient outcomes.As the Indian population ages and lifestyle factors evolve, the prevalence and awareness of these disorders rise, compelling stakeholders to develop strategies that address the growing healthcare demands associated with these neurodegenerative diseases.
Trends in technology and personalized medicine offer promising avenues for the management and treatment of these conditions, paving the way for improved life quality among affected individuals. The ongoing collaboration between government initiatives and healthcare sectors aims to bolster support systems, research initiatives, and public health campaigns focused on awareness and accessibility.In examining the India Neurodegenerative Disease Market, it becomes evident that the landscape is rapidly evolving, driven by a combination of demographic shifts, advancements in medical technology, and an increasing acknowledgment of the importance of mental health alongside physical well-being. As such, addressing neurodegenerative diseases within this market presents significant opportunities for stakeholders keen on making impactful contributions to the healthcare sector in India.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Neurodegenerative Disease Market Diagnosis Method Insights

The Diagnosis Method segment within the India Neurodegenerative Disease Market plays a crucial role in accurately identifying and managing neurodegenerative disorders. This segment encompasses various methods including Neurological Examination, which serves as the foundational step in assessing patients’ neurological health through clinical evaluations; Imaging Techniques that are pivotal in visualizing brain abnormalities, facilitating early detection of conditions like Alzheimer's and Parkinson's diseases; Cerebrospinal Fluid Analysis, which provides critical insights into the biochemical markers in the fluid surrounding the brain and spinal cord, thereby aiding in the diagnosis of various neurodegenerative diseases; and Electrophysiological Tests, which evaluate the electrical activity of the brain and nerves, thus contributing valuable information for diagnosing conditions such as multiple sclerosis.Each method serves a unique purpose, catering to different aspects of neurodegenerative diseases and collectively enhancing diagnostic accuracy and patient management in India.
The increasing prevalence of these diseases, along with advancements in diagnostic technologies, drives the need for sophisticated methods, highlighting the importance of this segment in the broader context of the India Neurodegenerative Disease Market. Effective diagnosis not only aids in timely medical intervention but also significantly contributes to improving the quality of life for affected individuals.

Neurodegenerative Disease Market Treatment Type Insights

The Treatment Type segment of the India Neurodegenerative Disease Market is crucial in addressing various neurological conditions affecting a significant population. Medication often serves as the foundation of treatment, focusing on alleviating symptoms and improving quality of life, which is vital for patients dealing with chronic conditions. Therapy plays an essential role by offering psychological support and cognitive rehabilitation, enhancing patients' functional abilities and emotional well-being.
Another significant aspect is Rehabilitation, which encompasses a range of services to help individuals recover lost skills or adapt to disabilities, underscoring the importance of tailored treatment plans in fostering independence.Surgical Interventions represent an impactful treatment approach for specific cases, allowing for direct intervention in progressive disorders, thereby improving outcomes.
Considering the high prevalence of neurodegenerative diseases in India, these treatment modalities are not only pivotal in managing these conditions but also highlight the growing demand for specialized care. The rising aging population and lifestyle changes are leading to an increase in the burden of these diseases, creating significant opportunities for advancements in treatment types within the India Neurodegenerative Disease Market.

Neurodegenerative Disease Market Route of Administration Insights

The Route of Administration segment within the India Neurodegenerative Disease Market reflects a diverse landscape, essential for effectively targeting treatment delivery to patients. Historically, oral administration has emerged as a favored choice due to its ease of use and patient compliance, making it significant in the management of chronic conditions like Alzheimer's disease. Injectable forms have gained traction for their quick delivery and effectiveness in acute scenarios, enhancing therapeutic outcomes.
Meanwhile, intravenous methods are crucial for patients needing immediate and potent medication, showcasing their importance in hospitals and specialized care frameworks.Transdermal patches present an innovative alternative, allowing for sustained drug release and minimizing gastrointestinal side effects, thus appealing to patients who prefer non-invasive options.
With the landscape of healthcare evolving, the development of advanced formulations and drug delivery systems is expected to drive growth in these routes, reflecting the need for customized and patient-centric approaches in neurodegenerative disease therapies. As India grapples with rising cases of neurodegenerative diseases, the strategic focus on these administration routes will be vital in improving treatment outcomes and patient quality of life.

India Neurodegenerative Disease Market Key Players and Competitive Insights

The competitive landscape of the India Neurodegenerative Disease Market is characterized by a growing focus on innovative treatment solutions, driven by increasing prevalence rates and evolving patient needs. The market encompasses a wide range of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, among others. As awareness of these conditions rises, so too does the demand for effective therapies capable of improving the quality of life for affected individuals. Companies operating in this space are increasingly investing in research and development to pioneer novel therapies, while also seeking strategic partnerships and collaborations to bolster their market position.
This dynamic environment is further propelled by advancements in biotechnology and pharmaceuticals, allowing for more targeted treatment options tailored to specific patient populations. Wockhardt has established itself as a significant player in the India Neurodegenerative Disease Market through its robust portfolio of pharmaceutical products and a commitment to research and development. The company's strengths lie in its strong manufacturing capabilities, ensuring a consistent supply of quality medications. Wockhardt's strategic focus on therapeutic areas relevant to neurodegenerative diseases, combined with its established distribution networks in India, allows it to maintain a competitive edge.
Furthermore, Wockhardt has been proactive in engaging with healthcare professionals and stakeholders, which enhances its credibility and fosters brand loyalty. The company's ability to innovate and adapt to market trends positions it as a formidable competitor in the Indian neurodegenerative sector, contributing meaningfully to the overall growth of the market.Intas Pharmaceuticals has made significant strides within the India Neurodegenerative Disease Market, offering a range of products that address various neurological conditions. Known for its commitment to quality and affordability, Intas has positioned itself as a reliable source of medications for patients and healthcare providers alike.
The company's strengths are reflected in its comprehensive pipeline of generics and specialty pharmaceuticals designed to treat neurodegenerative diseases, alongside a strong focus on research initiatives to advance therapeutic options. Intas Pharmaceuticals actively pursues mergers and acquisitions to expand its product portfolio and enhance its market presence, ensuring that it remains competitive. The firm’s collaborations with research institutions and participation in clinical trials further underscore its dedication to innovation in the neurodegenerative domain, reinforcing its status as a key player in the Indian market for these diseases.

Key Companies in the India Neurodegenerative Disease Market Include

• Wockhardt


• Intas Pharmaceuticals


• Dr. Reddy's Laboratories


• Sanofi India


• AbbVie


• Merck & Co.


• Biocon


• Zydus Cadila


• Pfizer


• AstraZeneca


• Novartis


• Cipla


• BristolMyers Squibb


• Sun Pharmaceutical Industries


• Eli Lilly and Company

India Neurodegenerative Disease Market Industry Developments

The India Neurodegenerative Disease Market has seen notable developments in recent months, particularly with major pharmaceutical companies such as Wockhardt, Dr. Reddy's Laboratories, and Biocon intensifying their focus on Research and Development for therapeutic solutions targeting diseases like Alzheimer's and Parkinson’s. In September 2023, Intas Pharmaceuticals launched a new formulation aimed at improving patient outcomes for dementia, further indicating the increasing competition within the sector.
Additionally, Sanofi India reported a significant growth valuation in their neurodegenerative pipeline, which has positively influenced their market position. There were reports of AstraZeneca entering collaborations to enhance existing therapies in October 2023, reinforcing the trend of partnership-driven innovation.
Regarding mergers and acquisitions, in August 2023, Eli Lilly and Company acquired a biotech firm that specializes in neurodegenerative therapies, a move that is set to strengthen its portfolio in India. The Indian government’s initiatives to bolster healthcare infrastructure have also contributed to a favorable environment for investment and growth in this market. The sector's expansion reflects a heightened awareness and urgency surrounding neurodegenerative diseases in India, driven by an aging population and rising incidences of these conditions.

India Neurodegenerative Disease Market Segmentation Insights

Neurodegenerative Disease Market Disease Type Outlook

• Alzheimer's Disease


• Parkinson's Disease


• Multiple Sclerosis


• Amyotrophic Lateral Sclerosis


• Huntington's Disease

Neurodegenerative Disease Market Diagnosis Method Outlook

• Neurological Examination


• Imaging Techniques


• Cerebrospinal Fluid Analysis


• Electrophysiological Tests

Neurodegenerative Disease Market Treatment Type Outlook

• Medication


• Therapy


• Rehabilitation


• Surgical Interventions

Neurodegenerative Disease Market Route of Administration Outlook

• Oral


• Injectable


• Intravenous


• Transdermal

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	1.1(USD Billion)
MARKET SIZE 2024	1.5(USD Billion)
MARKET SIZE 2035	4.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.326% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Wockhardt, Intas Pharmaceuticals, Dr. Reddy's Laboratories, Sanofi India, AbbVie, Merck & Co., Biocon, Zydus Cadila, Pfizer, AstraZeneca, Novartis, Cipla, BristolMyers Squibb, Sun Pharmaceutical Industries, Eli Lilly and Company
SEGMENTS COVERED	Disease Type, Diagnosis Method, Treatment Type, Route of Administration
KEY MARKET OPPORTUNITIES	Aging population growth, Increasing healthcare awareness, Advancements in telemedicine, Rising research funding, Enhanced drug development initiatives
KEY MARKET DYNAMICS	rising elderly population, increasing healthcare expenditure, advancements in research, growing awareness and diagnosis, rising prevalence of neurodegenerative disorders
COUNTRIES COVERED	India